Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone
@article{Simard2004IdentificationOT, title={Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone}, author={C. Simard and V. Michaud and B. Gibbs and R. Masse and E. Lessard and J. Turgeon}, journal={Xenobiotica}, year={2004}, volume={34}, pages={1013 - 1023} }
1. The objective was to identify the major cytochrome P450 enzyme(s) involved in the metabolism of domperidone. 2. Experiments were performed using human liver microsomes (HLMs), recombinant human cytochrome P450 enzymes, cytochrome P450 chemical inhibitors and monoclonal antibodies directed against cytochrome P450 enzymes. 3. Four metabolites were identified from incubations performed with HLMs and excellent correlations were observed between the formation of domperidone hydroxylated… CONTINUE READING
Topics from this paper
21 Citations
An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies.
- Chemistry, Medicine
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
- 2007
- 28
Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis
- Chemistry, Medicine
- Xenobiotica; the fate of foreign compounds in biological systems
- 2009
- 7
- Highly Influenced
Identification of domperidone metabolites in plasma and urine of gastroparesis patients with LC–ESI-MS/MS
- Chemistry, Medicine
- Xenobiotica; the fate of foreign compounds in biological systems
- 2013
- 5
- Highly Influenced
Domperidone interacts with pioglitazone but not with ondansetron via common CYP metabolism in vitro
- Chemistry, Medicine
- Xenobiotica; the fate of foreign compounds in biological systems
- 2014
- 4
Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes
- Biology, Medicine
- Pharmacology research & perspectives
- 2014
- 20
Elucidation of in vitro phase I metabolites of droperidol using UPLC-QTOF MS
- Chemistry, Medicine
- European Journal of Drug Metabolism and Pharmacokinetics
- 2014
Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
- Chemistry, Medicine
- Journal of pharmaceutical sciences
- 2010
- 66
Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information.
- Chemistry, Medicine
- Pharmacology & therapeutics
- 2010
- 85
- PDF
Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions
- Medicine, Biology
- Xenobiotica; the fate of foreign compounds in biological systems
- 2006
- 26
Decreased CYP3A Expression and Activity in Guinea Pig Models of Diet-Induced Metabolic Syndrome: Is Fatty Liver Infiltration Involved?
- Biology, Medicine
- Drug Metabolism and Disposition
- 2013
- 22
- PDF
References
SHOWING 1-10 OF 14 REFERENCES
Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
- Chemistry, Medicine
- Drug metabolism and disposition: the biological fate of chemicals
- 1995
- 623
Involvement of CYP2D6 activity in the N-oxidation of procainamide in man.
- Medicine
- Pharmacogenetics
- 1999
- 20
Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9.
- Chemistry, Medicine
- Xenobiotica; the fate of foreign compounds in biological systems
- 1995
- 305
Genetic polymorphism of cytochrome P450 3A5 in Chinese.
- Biology, Medicine
- Drug metabolism and disposition: the biological fate of chemicals
- 2001
- 85
- PDF
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
- Biology, Medicine
- Nature Genetics
- 2001
- 1,962
- PDF
Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist
- Medicine
- The Annals of pharmacotherapy
- 1999
- 209
- Highly Influential
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.
- Medicine
- Drugs
- 1982
- 268
Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders
- Medicine
- Circulation
- 2000
- 109
- PDF
Cardiac Arrhythmias during Cytotoxic Chemotherapy: Role of Domperidone
- Medicine
- Human toxicology
- 1985
- 39
- Highly Influential